PUBLISHER: TechNavio | PRODUCT CODE: 1756581

PUBLISHER: TechNavio | PRODUCT CODE: 1756581

Global BRAF Kinase Inhibitors Market 2025-2029

PUBLISHED: June 11, 2025

PAGES: 208 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The braf kinase inhibitors market is forecasted to grow by USD 2,162 mn during 2024-2029, accelerating at a CAGR of 9% during the forecast period. The report on the braf kinase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of braf kinase inhibitors, presence of patient assistance programs, and increasing prevalence of cancer.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	8%
CAGR	9%
Incremental Value	$2,162 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's braf kinase inhibitors market is segmented as below:

By Product

Dabrafenib
Sorafenib
Vemurafenib
Encorafenib

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Indication

Metastatic melanoma
Metastatic lung cancer
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expansion of research areas in braf kinase inhibitors as one of the prime reasons driving the braf kinase inhibitors market growth during the next few years. Also, growing strategic alliances and growing awareness of cancer will lead to sizable demand in the market.

The report on the braf kinase inhibitors market covers the following areas:

BRAF Kinase Inhibitors Market sizing
BRAF Kinase Inhibitors Market forecast
BRAF Kinase Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading braf kinase inhibitors market vendors that include Asana BioSciences LLC, Bayer AG, BeiGene Ltd., F. Hoffmann La Roche Ltd., Fore Biotherapeutics, Jazz Pharmaceuticals Plc, Kinnate Biopharma Inc., Nerviano Medical Sciences S.r.l, Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc., and Pierre Fabre SA. Also, the braf kinase inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73550

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global BRAF Kinase Inhibitors Market 2019 - 2023
- Historic Market Size - Data Table on Global BRAF Kinase Inhibitors Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global BRAF Kinase Inhibitors Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Dabrafenib - Market size and forecast 2024-2029
- Chart on Dabrafenib - Market size and forecast 2024-2029 ($ million)
- Data Table on Dabrafenib - Market size and forecast 2024-2029 ($ million)
- Chart on Dabrafenib - Year-over-year growth 2024-2029 (%)
- Data Table on Dabrafenib - Year-over-year growth 2024-2029 (%)
8.4 Sorafenib - Market size and forecast 2024-2029
- Chart on Sorafenib - Market size and forecast 2024-2029 ($ million)
- Data Table on Sorafenib - Market size and forecast 2024-2029 ($ million)
- Chart on Sorafenib - Year-over-year growth 2024-2029 (%)
- Data Table on Sorafenib - Year-over-year growth 2024-2029 (%)
8.5 Vemurafenib - Market size and forecast 2024-2029
- Chart on Vemurafenib - Market size and forecast 2024-2029 ($ million)
- Data Table on Vemurafenib - Market size and forecast 2024-2029 ($ million)
- Chart on Vemurafenib - Year-over-year growth 2024-2029 (%)
- Data Table on Vemurafenib - Year-over-year growth 2024-2029 (%)
8.6 Encorafenib - Market size and forecast 2024-2029
- Chart on Encorafenib - Market size and forecast 2024-2029 ($ million)
- Data Table on Encorafenib - Market size and forecast 2024-2029 ($ million)
- Chart on Encorafenib - Year-over-year growth 2024-2029 (%)
- Data Table on Encorafenib - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Indication

10.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)
10.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
10.3 Metastatic melanoma - Market size and forecast 2024-2029
- Chart on Metastatic melanoma - Market size and forecast 2024-2029 ($ million)
- Data Table on Metastatic melanoma - Market size and forecast 2024-2029 ($ million)
- Chart on Metastatic melanoma - Year-over-year growth 2024-2029 (%)
- Data Table on Metastatic melanoma - Year-over-year growth 2024-2029 (%)
10.4 Metastatic lung cancer - Market size and forecast 2024-2029
- Chart on Metastatic lung cancer - Market size and forecast 2024-2029 ($ million)
- Data Table on Metastatic lung cancer - Market size and forecast 2024-2029 ($ million)
- Chart on Metastatic lung cancer - Year-over-year growth 2024-2029 (%)
- Data Table on Metastatic lung cancer - Year-over-year growth 2024-2029 (%)
10.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.14 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Asana BioSciences LLC
- Asana BioSciences LLC - Overview
- Asana BioSciences LLC - Product / Service
- Asana BioSciences LLC - Key offerings
- SWOT
15.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.6 BeiGene Ltd.
- BeiGene Ltd. - Overview
- BeiGene Ltd. - Business segments
- BeiGene Ltd. - Key offerings
- BeiGene Ltd. - Segment focus
- SWOT
15.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.8 Fore Biotherapeutics
- Fore Biotherapeutics - Overview
- Fore Biotherapeutics - Product / Service
- Fore Biotherapeutics - Key offerings
- SWOT
15.9 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
15.10 Kinnate Biopharma Inc.
- Kinnate Biopharma Inc. - Overview
- Kinnate Biopharma Inc. - Product / Service
- Kinnate Biopharma Inc. - Key offerings
- SWOT
15.11 Nerviano Medical Sciences S.r.l
- Nerviano Medical Sciences S.r.l - Overview
- Nerviano Medical Sciences S.r.l - Product / Service
- Nerviano Medical Sciences S.r.l - Key offerings
- SWOT
15.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.13 Ono Pharmaceutical Co. Ltd.
- Ono Pharmaceutical Co. Ltd. - Overview
- Ono Pharmaceutical Co. Ltd. - Product / Service
- Ono Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.15 Pierre Fabre SA
- Pierre Fabre SA - Overview
- Pierre Fabre SA - Product / Service
- Pierre Fabre SA - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR73550

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Market Segmentation by Indication
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global BRAF Kinase Inhibitors Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product - Market share 2024-2029 (%)
Exhibits39: Data Table on Product - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product
Exhibits41: Data Table on Comparison by Product
Exhibits42: Chart on Dabrafenib - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Dabrafenib - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Dabrafenib - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Dabrafenib - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Sorafenib - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Sorafenib - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Sorafenib - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Sorafenib - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Vemurafenib - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Vemurafenib - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Vemurafenib - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Vemurafenib - Year-over-year growth 2024-2029 (%)
Exhibits54: Chart on Encorafenib - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Encorafenib - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Encorafenib - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Encorafenib - Year-over-year growth 2024-2029 (%)
Exhibits58: Market opportunity by Product ($ million)
Exhibits59: Data Table on Market opportunity by Product ($ million)
Exhibits60: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits61: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits62: Chart on Comparison by Distribution Channel
Exhibits63: Data Table on Comparison by Distribution Channel
Exhibits64: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Distribution Channel ($ million)
Exhibits77: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits78: Chart on Indication - Market share 2024-2029 (%)
Exhibits79: Data Table on Indication - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by Indication
Exhibits81: Data Table on Comparison by Indication
Exhibits82: Chart on Metastatic melanoma - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Metastatic melanoma - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Metastatic melanoma - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Metastatic melanoma - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Metastatic lung cancer - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Metastatic lung cancer - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Metastatic lung cancer - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Metastatic lung cancer - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits94: Market opportunity by Indication ($ million)
Exhibits95: Data Table on Market opportunity by Indication ($ million)
Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits99: Chart on Geographic comparison
Exhibits100: Data Table on Geographic comparison
Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits157: Market opportunity By Geographical Landscape ($ million)
Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits159: Impact of drivers and challenges in 2024 and 2029
Exhibits160: Overview on criticality of inputs and factors of differentiation
Exhibits161: Overview on factors of disruption
Exhibits162: Impact of key risks on business
Exhibits163: Companies covered
Exhibits164: Company ranking index
Exhibits165: Matrix on companies position and classification
Exhibits166: Asana BioSciences LLC - Overview
Exhibits167: Asana BioSciences LLC - Product / Service
Exhibits168: Asana BioSciences LLC - Key offerings
Exhibits169: SWOT
Exhibits170: Bayer AG - Overview
Exhibits171: Bayer AG - Business segments
Exhibits172: Bayer AG - Key news
Exhibits173: Bayer AG - Key offerings
Exhibits174: Bayer AG - Segment focus
Exhibits175: SWOT
Exhibits176: BeiGene Ltd. - Overview
Exhibits177: BeiGene Ltd. - Business segments
Exhibits178: BeiGene Ltd. - Key offerings
Exhibits179: BeiGene Ltd. - Segment focus
Exhibits180: SWOT
Exhibits181: F. Hoffmann La Roche Ltd. - Overview
Exhibits182: F. Hoffmann La Roche Ltd. - Business segments
Exhibits183: F. Hoffmann La Roche Ltd. - Key news
Exhibits184: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits185: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits186: SWOT
Exhibits187: Fore Biotherapeutics - Overview
Exhibits188: Fore Biotherapeutics - Product / Service
Exhibits189: Fore Biotherapeutics - Key offerings
Exhibits190: SWOT
Exhibits191: Jazz Pharmaceuticals Plc - Overview
Exhibits192: Jazz Pharmaceuticals Plc - Product / Service
Exhibits193: Jazz Pharmaceuticals Plc - Key news
Exhibits194: Jazz Pharmaceuticals Plc - Key offerings
Exhibits195: SWOT
Exhibits196: Kinnate Biopharma Inc. - Overview
Exhibits197: Kinnate Biopharma Inc. - Product / Service
Exhibits198: Kinnate Biopharma Inc. - Key offerings
Exhibits199: SWOT
Exhibits200: Nerviano Medical Sciences S.r.l - Overview
Exhibits201: Nerviano Medical Sciences S.r.l - Product / Service
Exhibits202: Nerviano Medical Sciences S.r.l - Key offerings
Exhibits203: SWOT
Exhibits204: Novartis AG - Overview
Exhibits205: Novartis AG - Business segments
Exhibits206: Novartis AG - Key news
Exhibits207: Novartis AG - Key offerings
Exhibits208: Novartis AG - Segment focus
Exhibits209: SWOT
Exhibits210: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits211: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits212: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits213: SWOT
Exhibits214: Pfizer Inc. - Overview
Exhibits215: Pfizer Inc. - Product / Service
Exhibits216: Pfizer Inc. - Key news
Exhibits217: Pfizer Inc. - Key offerings
Exhibits218: SWOT
Exhibits219: Pierre Fabre SA - Overview
Exhibits220: Pierre Fabre SA - Product / Service
Exhibits221: Pierre Fabre SA - Key offerings
Exhibits222: SWOT
Exhibits223: Inclusions checklist
Exhibits224: Exclusions checklist
Exhibits225: Currency conversion rates for US$
Exhibits226: Research methodology
Exhibits227: Information sources
Exhibits228: Data validation
Exhibits229: Validation techniques employed for market sizing
Exhibits230: Data synthesis
Exhibits231: 360 degree market analysis
Exhibits232: List of abbreviations

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ